Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) EBITDA Margin (2024 - 2025)

Nuvation Bio (NUVB) has disclosed EBITDA Margin for 2 consecutive years, with 87.52% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 79241.0% to 87.52% in Q4 2025 year-over-year; TTM through Dec 2025 was 326.52%, a 688226.0% increase, with the full-year FY2025 number at 326.52%, up 688226.0% from a year prior.
  • EBITDA Margin was 87.52% for Q4 2025 at Nuvation Bio, up from 423.81% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 87.52% in Q4 2025 to a low of 32236.17% in Q2 2024.